Backing good ideas with capital and competence
We invest in the most promising early-stage Technology and Life Science & Health startups.
We invest in the most promising early-stage Technology and Life Science & Health startups.
We are one of the most active early-stage VC investors in Finland, currently managing six VC funds with total capital of over €250M. Our team members have diverse backgrounds with lengthy entrepreneurial, financial and operational experience across different industries and geographies. We are usually the “first VC check” when entrepreneurs seek external funding.
Healthcare is undergoing a fundamental transformation from a one-pill-fits-all to a patient centric big data driven ecosystem. We invest in impactful science based projects at the intersection of R&D and product development.
Read more +
Nordics is a recognized innovation powerhouse, and home to multiple category defining tech unicorns and global industrial champions. We invest in early-stage startups driving digital transformation by developing new technologies and sustainable solutions.
Read more +
We invest in Finnish seed companies together with business angels.
Read more +
More information about our funds
Read more +
Our team has experience from VC investing since 2006
Currently manage six VC funds, all of which are in different maturity stages of the startup J-curve
Have completed +30 exits, most recently Forendo Pharma (M&A 2021), Makia (M&A 2021), Bioretec (IPO 2021), Ginolis (M&A 2021)
Total 90 portfolio companies across all sectors of Technology and Life Science & Health
Current portfolio includes category leaders such as DealDash, Primex Pharmaceuticals, ZenRobotics, FiksuRuoka, Ruokaboksi and Ogoship
Get access to like-minded ambitious founders & teams through matchmaking within our large and diverse pool of portfolio companies
Systematic fundraise model and in-house team that can support portfolio companies financing needs
Co-investor network includes domestic and international VCs, CVCs, industrial investors, family offices and high net worth individuals with whom we syndicate investments
Unique collaboration opportunities with leading corporations within Technology and Life Science & Health segments
Assets under management
VC funds
Portfolio companies
Explore our investment criteria and get
in touch to find out if we’re a match.
Analyst, Innovestor Venture Capital
Investment Director, Innovestor Life Science